Japan Age Related Macular Degeneration Drug Market Report 2016

Publisher Name :
Date: 15-Sep-2016
No. of pages: 119
Inquire Before Buying

Notes:

Sales, means the sales volume of Age Related Macular Degeneration Drug

Revenue, means the sales value of Age Related Macular Degeneration Drug

This report studies sales (consumption) of Age Related Macular Degeneration Drug in Japan market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Roche/Genentech

- Novartis

- Regeneron

- Bayer

- Valeant

- Allergan

- Alimera Sciences

- Ophthotech

- Acucela

- Ohr Pharmaceuticals

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Age Related Macular Degeneration Drug in each application, can be divided into

- Application 1

- Application 2

- Application 3

Japan Age Related Macular Degeneration Drug Market Report 2016

Table of Contents
Japan Age Related Macular Degeneration Drug Market Report 2016
1 Age Related Macular Degeneration Drug Overview
1.1 Product Overview and Scope of Age Related Macular Degeneration Drug
1.2 Classification of Age Related Macular Degeneration Drug
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Age Related Macular Degeneration Drug
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Japan Market Size Sales (Value) and Revenue (Volume) of Age Related Macular Degeneration Drug (2011-2021)
1.4.1 Japan Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2021)
1.4.2 Japan Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2021)
2 Japan Age Related Macular Degeneration Drug Competition by Manufacturers
2.1 Japan Age Related Macular Degeneration Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 Japan Age Related Macular Degeneration Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 Japan Age Related Macular Degeneration Drug Average Price by Manufactures (2015 and 2016)
2.4 Age Related Macular Degeneration Drug Market Competitive Situation and Trends
2.4.1 Age Related Macular Degeneration Drug Market Concentration Rate
2.4.2 Age Related Macular Degeneration Drug Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 Japan Age Related Macular Degeneration Drug Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 Japan Age Related Macular Degeneration Drug Sales and Market Share by Type (2011-2016)
3.2 Japan Age Related Macular Degeneration Drug Revenue and Market Share by Type (2011-2016)
3.3 Japan Age Related Macular Degeneration Drug Price by Type (2011-2016)
3.4 Japan Age Related Macular Degeneration Drug Sales Growth Rate by Type (2011-2016)
4 Japan Age Related Macular Degeneration Drug Sales (Volume) by Application (2011-2016)
4.1 Japan Age Related Macular Degeneration Drug Sales and Market Share by Application (2011-2016)
4.2 Japan Age Related Macular Degeneration Drug Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 Japan Age Related Macular Degeneration Drug Manufacturers Profiles/Analysis
5.1 Roche/Genentech
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Roche/Genentech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Novartis
5.2.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Novartis Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Regeneron
5.3.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Regeneron Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Bayer
5.4.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Bayer Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Valeant
5.5.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Valeant Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Allergan
5.6.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Allergan Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Alimera Sciences
5.7.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Alimera Sciences Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Ophthotech
5.8.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Ophthotech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Acucela
5.9.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Acucela Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Ohr Pharmaceuticals
5.10.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Ohr Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
6 Age Related Macular Degeneration Drug Manufacturing Cost Analysis
6.1 Age Related Macular Degeneration Drug Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Age Related Macular Degeneration Drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 Japan Age Related Macular Degeneration Drug Market Forecast (2016-2021)
10.1 Japan Age Related Macular Degeneration Drug Sales, Revenue Forecast (2016-2021)
10.2 Japan Age Related Macular Degeneration Drug Sales Forecast by Type (2016-2021)
10.3 Japan Age Related Macular Degeneration Drug Sales Forecast by Application (2016-2021)
10.4 Age Related Macular Degeneration Drug Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Age Related Macular Degeneration Drug
Table Classification of Age Related Macular Degeneration Drug
Figure Japan Sales Market Share of Age Related Macular Degeneration Drug by Type in 2015
Table Application of Age Related Macular Degeneration Drug
Figure Japan Sales Market Share of Age Related Macular Degeneration Drug by Application in 2015
Figure Japan Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2021)
Figure Japan Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2021)
Table Japan Age Related Macular Degeneration Drug Sales of Key Manufacturers (2015 and 2016)
Table Japan Age Related Macular Degeneration Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Age Related Macular Degeneration Drug Sales Share by Manufacturers
Figure 2016 Age Related Macular Degeneration Drug Sales Share by Manufacturers
Table Japan Age Related Macular Degeneration Drug Revenue by Manufacturers (2015 and 2016)
Table Japan Age Related Macular Degeneration Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Japan Age Related Macular Degeneration Drug Revenue Share by Manufacturers
Table 2016 Japan Age Related Macular Degeneration Drug Revenue Share by Manufacturers
Table Japan Market Age Related Macular Degeneration Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Japan Market Age Related Macular Degeneration Drug Average Price of Key Manufacturers in 2015
Figure Age Related Macular Degeneration Drug Market Share of Top 3 Manufacturers
Figure Age Related Macular Degeneration Drug Market Share of Top 5 Manufacturers
Table Japan Age Related Macular Degeneration Drug Sales by Type (2011-2016)
Table Japan Age Related Macular Degeneration Drug Sales Share by Type (2011-2016)
Figure Japan Age Related Macular Degeneration Drug Sales Market Share by Type in 2015
Table Japan Age Related Macular Degeneration Drug Revenue and Market Share by Type (2011-2016)
Table Japan Age Related Macular Degeneration Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Age Related Macular Degeneration Drug by Type (2011-2016)
Table Japan Age Related Macular Degeneration Drug Price by Type (2011-2016)
Figure Japan Age Related Macular Degeneration Drug Sales Growth Rate by Type (2011-2016)
Table Japan Age Related Macular Degeneration Drug Sales by Application (2011-2016)
Table Japan Age Related Macular Degeneration Drug Sales Market Share by Application (2011-2016)
Figure Japan Age Related Macular Degeneration Drug Sales Market Share by Application in 2015
Table Japan Age Related Macular Degeneration Drug Sales Growth Rate by Application (2011-2016)
Figure Japan Age Related Macular Degeneration Drug Sales Growth Rate by Application (2011-2016)
Table Roche/Genentech Basic Information List
Table Roche/Genentech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche/Genentech Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Regeneron Basic Information List
Table Regeneron Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Regeneron Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Valeant Basic Information List
Table Valeant Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Valeant Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Alimera Sciences Basic Information List
Table Alimera Sciences Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alimera Sciences Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Ophthotech Basic Information List
Table Ophthotech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ophthotech Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Acucela Basic Information List
Table Acucela Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Acucela Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Ohr Pharmaceuticals Basic Information List
Table Ohr Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ohr Pharmaceuticals Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Age Related Macular Degeneration Drug
Figure Manufacturing Process Analysis of Age Related Macular Degeneration Drug
Figure Age Related Macular Degeneration Drug Industrial Chain Analysis
Table Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2015
Table Major Buyers of Age Related Macular Degeneration Drug
Table Distributors/Traders List
Figure Japan Age Related Macular Degeneration Drug Production and Growth Rate Forecast (2016-2021)
Figure Japan Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2016-2021)
Table Japan Age Related Macular Degeneration Drug Production Forecast by Type (2016-2021)
Table Japan Age Related Macular Degeneration Drug Consumption Forecast by Application (2016-2021)
  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • Efficacy of Stand-alone Power Sources Drive The Global Distributed Energy Generation Market
    The global market for distributed energy generation is expected to magnify at a momentous CAGR of 11.4% between 2016 and 2020. The small-scale generation of electricity, oscillating from a few kilowatts to multitudes of megawatts, is denoted as distributed energy generation. In this process, power is usually produced using renewable resources or by generators during consumption. [...]
  • Global Organic Food Market Makes A Mark in Developed Economies
    Buyers throughout the world are becoming more and more health cognizant, which has occasioned in an alteration in their palates and inclinations. The global organic food market was worth US$88.1 billion in 2015 is anticipated to record a CAGR of over 16% between 2015 and 2020. Amongst the various different food products available, the fruits [...]
  • Europe Heparin Market Report 2017
    Published: 23-Jan-2017        Price: US 3900 Onwards        Pages: 104
    Notes: Sales, means the sales volume of Heparin Revenue, means the sales value of Heparin This report studies sales (consumption) of Heparin in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - GSK - Sanofi - Leo Pharma A/S - Pfizer Inc - Fresenius - Hospira......
  • Europe Erythropoietin Market Report 2017
    Published: 23-Jan-2017        Price: US 3900 Onwards        Pages: 119
    Notes: Sales, means the sales volume of Erythropoietin Revenue, means the sales value of Erythropoietin This report studies sales (consumption) of Erythropoietin in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Amgen Inc - Johnson & Johnson - Hospira Inc - Roche -......
  • Global Loratadine Sales Market Report 2017
    Published: 23-Jan-2017        Price: US 4000 Onwards        Pages: 109
    Notes: Sales, means the sales volume of Loratadine Revenue, means the sales value of Loratadine This report studies sales (consumption) of Loratadine in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Merck & Co - Bayer Group - Perrigo - Sun Pharma - Apotex - Pfizer......
  • Global Herbal Medicine Sales Market Report 2017
    Published: 23-Jan-2017        Price: US 4000 Onwards        Pages: 105
    Notes: Sales, means the sales volume of Herbal Medicine Revenue, means the sales value of Herbal Medicine This report studies sales (consumption) of Herbal Medicine in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Tsumura - Schwabe - Madaus - Weleda - Blackmores - A......
  • Global Recombinant Glycosylated Proteins Market Professional Survey Report 2017
    Published: 23-Jan-2017        Price: US 3500 Onwards        Pages: 125
    Notes: Production, means the output of Recombinant Glycosylated Proteins Revenue, means the sales value of Recombinant Glycosylated Proteins This report studies Recombinant Glycosylated Proteins in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global......
  • Global Hemodialysis Powder Solution Market Professional Survey Report 2017
    Published: 23-Jan-2017        Price: US 3500 Onwards        Pages: 129
    Notes: Production, means the output of Hemodialysis Powder Solution Revenue, means the sales value of Hemodialysis Powder Solution This report studies Hemodialysis Powder Solution in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with p......
  • Global Hard Capsule Gelatin Market Professional Survey Report 2017
    Published: 23-Jan-2017        Price: US 3500 Onwards        Pages: 120
    Notes: Production, means the output of Hard Capsule Gelatin Revenue, means the sales value of Hard Capsule Gelatin This report studies Hard Capsule Gelatin in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenu......
  • Global Depression Drugs Market Professional Survey Report 2017
    Published: 23-Jan-2017        Price: US 3500 Onwards        Pages: 127
    Notes: Production, means the output of Depression Drugs Revenue, means the sales value of Depression Drugs This report studies Depression Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market......
  • Global Bone Therapeutic Market Professional Survey Report 2017
    Published: 23-Jan-2017        Price: US 3500 Onwards        Pages: 123
    Notes: Production, means the output of Bone Therapeutic Revenue, means the sales value of Bone Therapeutic This report studies Bone Therapeutic in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs